Sign In
Buy VKTX
$32.37
+1.99 (+6.55%)
At Close: Jun 22, 2026
Profiting from the Crowd: 3 Stocks Set to Surge on Retail Investor Enthusiasm
07:40am, Saturday, 08'th Jun 2024
Many people are looking for stocks to buy, driven by just one thing: fear. Whether it is the fear of losing it all or the fear of missing out (FOMO), investors tend to run in packs.
Viking Therapeutics, Inc. (VKTX) Advances While Market Declines: Some Information for Investors
06:46pm, Friday, 07'th Jun 2024
Viking Therapeutics, Inc. (VKTX) concluded the recent trading session at $55.99, signifying a +1.78% move from its prior day's close.
Is Viking Therapeutics Stock a Buy on the Dip?
07:45am, Thursday, 06'th Jun 2024
Viking Therapeutics stock took a hit this week in response to a clinical update for its midstage liver disease drug. This pullback seems unwarranted, given the company's pivot to weight loss.
Viking (VKTX) Falls 10% Despite Upbeat NASH Study Results
11:31am, Wednesday, 05'th Jun 2024
Viking Therapeutics (VKTX) reports promising 52-week treatment data from a mid-stage study on its experimental NASH drug. However, shares drop as management did not provide any info on future plans.
Up to 75% of Patients Treated with VK2809 Achieved NASH Resolution with No Worsening of Fibrosis as Compared to 29% for Placebo (p=0.0001) Up to 57% of VK2809-Treated Patients Achieved ≥1-Stage Impr
1 Disruptive Biotech Stock to Buy Now, and 1 to Consider
10:15am, Monday, 03'rd Jun 2024
Biotechs that aspire to be disruptive are quite risky. However, they do offer the chance of disproportionate rewards.
The Gold Rush for Weight Loss Drugs Is Here. These 3 Latecomers Could Be Worth a Buy.
09:00am, Monday, 03'rd Jun 2024
Eli Lilly and Novo Nordisk aren't the only ones making anti-obesity drugs. Amgen, AstraZeneca, and Viking Therapeutics have credible candidates.
Here's Why Viking Therapeutics, Inc. (VKTX) Gained But Lagged the Market Today
06:46pm, Friday, 31'st May 2024
The latest trading day saw Viking Therapeutics, Inc. (VKTX) settling at $62.26, representing a +0.78% change from its previous close.
Viking Therapeutics to Participate at Upcoming Investor Conferences
04:03pm, Thursday, 30'th May 2024
SAN DIEGO , May 30, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic an
3 Of My Favorite Names On Wells Fargo's Biotech Buyout List
02:45pm, Wednesday, 29'th May 2024
Wells Fargo recently tagged numerous midcap biotech/biopharma stocks as potential buyout targets. There are many names on this list that have been mentioned as acquisition candidates in the past and t
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
06:30am, Wednesday, 29'th May 2024
Biotech stocks are not for the faint of heart. It is a sector that can provide life-changing gains or cause an investment to head towards zero.
Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It?
10:31am, Tuesday, 28'th May 2024
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
If You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have Today
08:31am, Sunday, 26'th May 2024
Viking Therapeutics develops therapies to treat obesity. Several of its drug candidates showed promising data during phase 2 trials.
3 Biotech Stocks That Could Be Millionaire-Makers: May Edition
12:00pm, Saturday, 25'th May 2024
As we delve deeper into 2024, biotech stocks are commanding the attention of growth-focused investors. Despite facing volatility and regulatory challenges in recent years, biotech is poised for a resu
Where Will Viking Therapeutics Be in 5 Years?
08:15am, Saturday, 25'th May 2024
Viking has multiple GLP-1 drugs in development that have been generating impressive results. Given this market's potential, its financials could improve dramatically if one of its drugs is approved.
